Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Observational Study of Trifluridine/ Tipiracil (TAS-102) in Chemorefractory Metastatic Colorectal Cancer (mCRC) in Greece. Real World Data on Clinical Benefit.

NCT04965870 is registered in ClinicalTrials.gov with Hellenic Study Group of Psychoneuroimmunology in Cancer as lead sponsor.

NCT NCT04965870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04965870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Observational Study of Trifluridine/ Tipiracil (TAS-102) in Chemorefractory Metastatic Colorectal Cancer (mCRC) in Greece. Real World Data on Clinical Benefit.
Lead sponsor
Hellenic Study Group of Psychoneuroimmunology in Cancer
Phase
Observational
Overall status
Completed
Start date
June 30, 2021
Completion date
December 20, 2021
Enrollment
200 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer